Needle-free subcutaneous sumatriptan for triptan users requiring a change in migraine therapy: efficacy and impact on patient-rated functionality, satisfaction, and confidence

By Rothrock John F.   Cady Roger K.   Aurora Sheena K.   Brandes Jan Lewis   Myers Judith A.   Fox Anthony W.   Farr Stephen J.  

Current Medical Research and Opinion, Vol. 27, Iss. 11, 2011-11 ,pp. : 2185-2191

Informa Healthcare

Access to resources Recommend Favorite

A “Lifesaving” Migraine Attack

By  

HEADACHE, Vol. 55, Iss. 6, 2015-06 ,pp. : 846-848

John Wiley & Sons Inc

Access to resources Recommend Favorite

Adding Additional Acute Medications to a Triptan Regimen for Migraine and Observed Changes in Headache‐Related Disability: Results From the American Migraine Prevalence and Prevention (AMPP) Study

By  

HEADACHE, Vol. 55, Iss. 6, 2015-06 ,pp. : 825-839

John Wiley & Sons Inc

Access to resources Recommend Favorite

How treatment priorities influence triptan preferences in clinical practice: perspectives of migraine sufferers, neurologists, and primary care physicians

By Lipton R. B.   Cutrer F. M.   Goadsby P. J.   Ferrari M. D.   Dodick D. W.   McCrory D.   Liberman J. N.   Williams P.  

Current Medical Research and Opinion, Vol. 21, Iss. 3, 2005-03 ,pp. : 413-424

Informa Healthcare

Access to resources Recommend Favorite

Migraine Attack Treatment : A Tailor-made Suit, Not One Size Fits All

By  

Recent Patents on CNS Drug Discovery, Vol. 9, Iss. 1, 2014-04 ,pp. : 26-40

Bentham Science Publishers

Access to resources Recommend Favorite